Viviane carneiro biography of albert einstein
•
Abstract
This analysis, using data from the Brazilian kidney transplant (KT) COVID-19 study, seeks to develop a prediction score to assist in COVID-19 risk stratification in KT recipients. In this study, 1379 patients (35 sites) were enrolled, and a machine learning approach was used to fit models in a derivation cohort. A reduced Elastic Net model was selected, and the accuracy to predict the 28-day fatality after the COVID-19 diagnosis, assessed by the area under the ROC curve (AUC-ROC), was confirmed in a validation cohort. The better calibration values were used to build the applicable ImAgeS score. The 28-day fatality rate was 17% (n = 235), which was associated with increasing age, hypertension and cardiovascular disease, higher body mass index, dyspnea, and use of mycophenolate acid or azathioprine. Higher kidney graft function, longer time of symptoms until COVID-19 diagnosis, presence of anosmia or coryza, and use of mTOR inhibitor were associated with reduced risk of de
•
Abstract
Ketamine is unique among anesthetics and analgesics. The drug is a rapid-acting general anesthetic that produces an anesthetic state characterized bygd profound analgesia, preserved pharyngeal-laryngeal reflexes, normal or slightly enhanced skeletal muscle tone, cardiovascular and respiratory stimulation, and occasionally a transient and minimal respiratory nedstämdhet. Research has demonstrated the efficacy of its use on anesthesia, pain, palliative care, and intensive care. Recently, it has been used for postoperative and chronic pain, as an adjunct in psychotherapy, as a treatment for nedstämdhet and posttraumatic stress disorder, as a procedural sedative, and as a treatment for respiratory and/or neurologic clinical conditions. Despite being a safe and widely used drug, many physicians, such as intensivists and those practicing in emergency care, are not aware of the current clinical applications of ketamine. The objective of this narrative literature review is to present
•
Management Board
Defines B3’s strategy and annual budget. As well as deciding when to call Shareholders’ Meetings and proposing how to distribute earnings, it is responsible for electing and overseeing the executive officers and choosing the independent auditors. The board meets monthly, and its members are elected at a Shareholders’ Meeting. Their terms of office is two years, with reelection permitted. They cannot be elected or appointed to the Company’s Executive Board.
| Name | Position |
|---|---|
| Antonio Carlos Quintella | Chairman (Independent and Unbound Director) |
| Election date: 06.2023 / Term of office: until 2025 Annual Meeting He is a founding member and CEO of Canvas Capital and a member of the Votorantim S.A. Board of Directors. He was the Chairman of Credit Suisse Hedging-Griffo, headquartered in São Paulo (2012-2014), and CEO of Credit Suisse Americas and member of the Executive Board of Credit Suisse Group (2010-2012) and CEO of Credit Suisse B | |